Based on this observation, it is also hypothesized that the higher activation of FAK in SCLC than in NSCLC is responsible for the more aggressive biological and clinical behavior of SCLC, known for the rapid growth, early, and frequent metastasis, and the poorest OS among all lung cancer types. Here, PTK2 is linked to non-small cell lung carcinoma.